Suppr超能文献

用二巯基丁二酸(DMSA)和乙二胺四乙酸(EDTA)进行激发螯合:不同途径进入铅储存部位的证据。

Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites.

作者信息

Lee B K, Schwartz B S, Stewart W, Ahn K D

机构信息

Institute of Industrial Medicine, Soonchunhyang University, Chunan, Republic of Korea.

出版信息

Occup Environ Med. 1995 Jan;52(1):13-9. doi: 10.1136/oem.52.1.13.

Abstract

OBJECTIVES--To validate a provocative chelation test with 2,3-dimercaptosuccinic acid (DMSA) by direct comparison with the standard ethylene diamine tetraacetic acid (EDTA) test in the same subjects; and to compare and contrast the predictors of lead excretion after DMSA with those after EDTA. A metal chelating agent given orally, DMSA may mobilise and enhance the excretion of lead from the storage sites in the body that are most directly relevant to the health effects of lead. A provocative chelation test with DMSA could thus have wide potential application in clinical care and epidemiological studies. METHODS--34 male lead workers in the Republic of Korea were given a single oral dose of 10 mg/kg DMSA, urine was collected over the next eight to 24 hours, and urine volume and urinary lead concentration determined at 0, 2, 4, 6, 8, and 24 hours. Either two weeks before or two weeks after the dose of DMSA 17 of these workers also received 1 g intravenous EDTA followed by an eight hour urine collection with fractionation at 0, 2, 4, 6, and 8 hours. RESULTS--Urinary lead concentration peaked at two hours after DMSA and four hours after EDTA. Lead excretion after DMSA was less than after EDTA, and cumulative excretion after DMSA plateaued at six to eight hours. The two hour and four hour cumulative lead excretions after DMSA were highly correlated with the eight hour total (r = 0.76 and 0.95). In multiple linear regression analyses, blood lead was found to be an important predictor of EDTA-chelatable lead, whereas urinary aminolevulinic acid (ALAU) was associated with DMSA-chelatable lead. Notably, lead excretion after DMSA was greatly increased if EDTA was given first. An earlier dose of EDTA also modified the relation between ALAU and DMSA-chelatable lead in that workers who received EDTA before DMSA showed a much steeper dose-response relation between these two measures. CONCLUSIONS--The predictors of lead excretion after DMSA and EDTA are different and an earlier dose of EDTA may increase lead excretion after a subsequent dose of DMSA. The results suggest that two hour or four hour cumulative lead excretion after DMSA may provide an estimate of lead in storage sites that are most directly relevant to the health effects of lead.

摘要

目的——通过在同一受试者中与标准乙二胺四乙酸(EDTA)试验直接比较,验证2,3 - 二巯基丁二酸(DMSA)激发螯合试验;并比较和对比DMSA后与EDTA后铅排泄的预测因素。口服的金属螯合剂DMSA可能会动员并增强体内与铅对健康影响最直接相关的储存部位的铅排泄。因此,DMSA激发螯合试验在临床护理和流行病学研究中可能具有广泛的潜在应用。方法——34名韩国男性铅作业工人单次口服10mg/kg DMSA,在接下来的8至24小时内收集尿液,并在0、2、4、6、8和24小时测定尿量和尿铅浓度。在给予DMSA剂量的两周前或两周后,这些工人中的17人还接受了1g静脉注射EDTA,随后收集8小时尿液,并在0、2、4、6和8小时进行分段收集。结果——DMSA后尿铅浓度在2小时达到峰值,EDTA后在4小时达到峰值。DMSA后的铅排泄量低于EDTA后,DMSA后的累积排泄量在6至8小时达到平稳。DMSA后2小时和4小时的累积铅排泄量与8小时总量高度相关(r = 0.76和0.95)。在多元线性回归分析中,发现血铅是EDTA可螯合铅的重要预测因素,而尿δ-氨基乙酰丙酸(ALAU)与DMSA可螯合铅相关。值得注意的是,如果先给予EDTA,DMSA后的铅排泄量会大大增加。较早剂量的EDTA还改变了ALAU与DMSA可螯合铅之间的关系,即在DMSA之前接受EDTA的工人中,这两种测量之间的剂量反应关系要陡峭得多。结论——DMSA和EDTA后铅排泄的预测因素不同,较早剂量的EDTA可能会增加随后剂量DMSA后的铅排泄量。结果表明,DMSA后2小时或4小时的累积铅排泄量可能提供与铅对健康影响最直接相关的储存部位中铅的估计值。

相似文献

1
Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites.
Occup Environ Med. 1995 Jan;52(1):13-9. doi: 10.1136/oem.52.1.13.
5
A comparison of different lead biomarkers in their associations with lead-related symptoms.
Int Arch Occup Environ Health. 2000 Jul;73(5):298-304. doi: 10.1007/s004200000132.
10
Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
QJM. 2009 Oct;102(10):721-32. doi: 10.1093/qjmed/hcp114. Epub 2009 Aug 20.

引用本文的文献

1
A State-of-the-Science Review on Metal Biomarkers.
Curr Environ Health Rep. 2023 Sep;10(3):215-249. doi: 10.1007/s40572-023-00402-x. Epub 2023 Jun 20.
5
Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy.
J Am Coll Cardiol. 2016 May 24;67(20):2411-2418. doi: 10.1016/j.jacc.2016.02.066.
6
The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues.
Environ Health Perspect. 2007 Mar;115(3):455-62. doi: 10.1289/ehp.9783. Epub 2006 Dec 22.
8
Diagnostic chelation challenge with DMSA: a biomarker of long-term mercury exposure?
Environ Health Perspect. 2001 Feb;109(2):167-71. doi: 10.1289/ehp.01109167.
9
Predictors of DMSA chelatable lead, tibial lead, and blood lead in 802 Korean lead workers.
Occup Environ Med. 2001 Feb;58(2):73-80. doi: 10.1136/oem.58.2.73.

本文引用的文献

1
Physiologically based models for bone-seeking elements. IV. Kinetics of lead disposition in humans.
Toxicol Appl Pharmacol. 1993 Jan;118(1):16-29. doi: 10.1006/taap.1993.1004.
3
Chelatable lead body burden (by calcium-disodium EDTA) and blood lead concentration in man.
J Occup Med. 1981 Jan;23(1):39-43. doi: 10.1097/00043764-198101000-00017.
4
The role of lead in gout nephropathy.
N Engl J Med. 1981 Feb 26;304(9):520-3. doi: 10.1056/NEJM198102263040905.
5
Lead in finger-bone analysed in vivo in active and retired lead workers.
Am J Ind Med. 1984;6(6):447-57. doi: 10.1002/ajim.4700060608.
6
Contribution of lead to hypertension with renal impairment.
N Engl J Med. 1983 Jul 7;309(1):17-21. doi: 10.1056/NEJM198307073090104.
7
Lead concentrations in human tissues.
Br J Ind Med. 1970 Oct;27(4):339-51. doi: 10.1136/oem.27.4.339.
9
Comparison of two in vitro methods of bone lead analysis and the implications for in vivo measurements.
Phys Med Biol. 1986 Nov;31(11):1267-74. doi: 10.1088/0031-9155/31/11/008.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验